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Diet is a major factor determining gut microbiota composition and perturbances in this
complex ecosystem are associated with the inflammatory bowel disease (IBD). Here,
we used gnotobiotic approach to analyze, how interaction between diet rich in proteins
and gut microbiota influences the sensitivity to intestinal inflammation in murine model
of ulcerative colitis. We found that diet rich in animal protein (aHPD) exacerbates acute
dextran sulfate sodium (DSS)-induced colitis while diet rich in plant protein (pHPD) does
not. The deleterious effect of aHPD was also apparent in chronic DSS colitis and was
associated with distinct changes in gut bacteria and fungi. Therefore, we induced acute
DSS-colitis in germ-free mice and transferred gut microbiota from aCD or aHPD fed
mice to find that this effect requires presence of microbes and aHPD at the same
time. The aHPD did not change the number of regulatory T cells or Th17 cells and
still worsened the colitis in immuno-deficient RAG2 knock-out mice suggesting that this
effect was not dependent on adaptive immunity. The pro-inflammatory effect of aHPD
was, however, abrogated when splenic macrophages were depleted with clodronate
liposomes. This treatment prevented aHPD induced increase in colonic Ly-6Chigh
pro-inflammatory monocytes, but the ratio of resident Ly-6C−/low macrophages was
not changed. These data show that the interactions between dietary protein of animal
origin and gut microbiota increase sensitivity to intestinal inflammation by promoting
pro-inflammatory response of monocytes.
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INTRODUCTION
Commensal gut microbiota significantly influences the host’s
metabolism. Its catabolic and anabolic pathways allow it to
use a broad spectrum of substrates including ingested items,
substances secreted into the gut lumen or those directly produced
by (other) microbes (1). Out of these sources, diet represents the
major bulk, and since it is the easiest one to influence, dietary
intervention of microbiota and health brings most attention.
Changes in diet drive microbes to adapt to a new substrate,
thus induce profound changes in microbiota that could improve
the host’s ability to adapt to the environment. The changes
induced by dietary extremes may persist for a long time and
thus reflect the host’s diet (2). These adaptive changes are
similar across different mammalian lineages and have important
implications for host’s health (3). Dietary interventions can
also induce rapid and reproducible changes in microbiota and
enrich the community with transient food-borne microbes that
are not capable of long-time colonization (4). Indeed, ∼15%
of microbial operational taxonomic units (OTUs) show strong
diurnal fluctuation due to the timing of food intake thus
synchronize circadian clock down to the level of metabolic
processes. Interestingly, long-term violation of this fine-tuned
system in shift workers and frequent flyers could cause temporal
dysbiosis with serious metabolic consequences (5).
Disruption of gut microbiota, i.e., dysbiosis, has been recently
linked to pathogenesis of inflammatory bowel disease (IBD)
(6), metabolic syndrome (7, 8), cardiovascular diseases (9),
neurological disorders (10), and even cancer (11). There is an
increasing body of evidence that dietary macronutrients may
both promote or counteract dysbiosis and its consequences
(12). Both short- and long-term dietary interventions lead to
substantial changes in gut microbiota and can influence pro-
inflammatory status of gut mucosa (13, 14). There is a well-
recognized link between diet and IBD. Retrospective studies
found that high intake of sucrose, red meat, or margarine
increases the relative risk for IBD, consumption of cereal, fruit
and vegetable or high-fiber food in general decreases it (15–18).
Increased dietary intake of animal proteins has been proposed
as a factor contributing to the Crohn’s disease development
already several decades ago (19, 20). Metabolism of proteins
mainly takes place in the distal colon where carbohydrate-based
sources are reduced and bacteria can switch their metabolism
to asaccharolytic one. Depending on the source of the protein,
animal, and diary proteins are almost completely degraded
during passage whereas plant proteins are less degraded and
reach large intestine in bigger amounts (21). Degradation of
proteins, peptides and amino acids leads to production of
various biologically active metabolites, such as branched-chain
fatty acids, ammonium, hydrogen sulfide, p-cresol, phenolic
and indolic derivates, which could influence the epithelial cells
viability and proliferation, thus affecting gut barrier function and
immune response. Some of these activities have been linked to
the pathogenesis of IBD and other gastrointestinal diseases (22).
Several studies analyzed the effect of diet rich in protein
(HPD) on gastrointestinal physiology and basic epithelial
response. Rats consuming HPD had different microbiota
composition and metabolic activity, altered colonocytes
morphology and enzymatic pathways, more goblet cells
and increased production of mucin when compared to
rats consuming normoproteic diet (23–25). Induction of
experimental inflammation in mice fed by HPD led to severe
colitis with high mortality (26). Recently, study analyzing the
macronutrient source and quantity found that high amount of
dietary casein most significantly contributes to colitis sensitivity
while psyllium fiber sensitivity decreases. In both these cases,
microbiota composition, and density and gut barrier functions
were the major mechanisms involved (27). Taken together these
studies showed that various dietary proteins can change host’s
response to gut microbiota including fine tuning of mucosal
immune system and eventually influence the susceptibility to
experimental colitis.
Products of intestinal microbiota metabolism (such as short-
chain fatty acids, SCFA) influence T cell maturation and activity
and may regulate the host’s immune system both directly and
indirectly via other cells (28, 29). By attaching to the gut
epithelium, microbes can regulate the balance in gut T cell
response. Depending on the particular microbe, they may induce
either regulatory T cells or pro-inflammatory Th17 cells (30, 31).
In either case, mononuclear cells in the gut mucosa play crucial
role in mucosal immune response and in sensitivity to intestinal
inflammation. In fact, mononuclear cells such as macrophages
residing in the gut mucosa contribute to the local tolerance
and non-inflammatory environment, by producing IL-10 and
PGE2 and not responding to bacterial lipopolysaccharide (32).
Whereas, Ly6C+ blood monocytes are recruited to the mucosa
in response to pro-inflammatory stimulation; outnumbering
resident macrophages and producing large quantities of IL-1β
and TNF-α (33, 34).
The aim of this study was to analyze how dietary protein
can contribute to the IBD pathogenesis, with special focus
on microbial and immunological mechanisms using two sets
(animal and plant protein-based) of fully synthetic normo- and
hyper-proteic diets. The gnotobiotic experiments were employed
to decipher the importance of host-diet-microbiota interaction
and its consequences for acute intestinal inflammation.
MATERIALS AND METHODS
Animals
Immuno-competent BALB/c and immuno-deficient RAG2
knock-out mice on BALB/c background were obtained from
breeding colony of the Institute of Physiology of the CAS
and Institute of Microbiology of the CAS, respectively, and all
experiments were performed under either conventional or germ-
free conditions at the Institute of Microbiology of the CAS. Mice
were fed with Maintenance diet for rats and mice No. 1324
(Altromin Spezialfutter, GmbH & Co. KG, Germany), unless
stated otherwise. Different experimental groups were housed
in separate cages. In addition to that, germ-free mice were
housed in Trexler-type plastic isolators under sterile conditions,
supplied with sterile water for several generations before the
experiments started. This study was carried out in accordance
with the recommendations of the ethics standards defined by the
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EU legislation on the use of experimental animals (2010/63/EU)
and Czech animal welfare act. The protocol was approved by
the Institute of Microbiology animal care and use committee
(approval ID: 85/2015 and 108/2016).
Diets and Experimental Design
In most experiments, shortly after weaning, the mice were
switched either to animal protein-based diet—control (aCD, 176
g/kg crude protein; Cat# C1000) and high-protein diet (aHPD,
514 g/kg crude protein; Cat# C1001) or plant protein-based
diet—control (pCD, 173 g/kg crude protein; Cat# C 1000/110007)
and high-protein diet (pHPD, 500 g/kg crude protein; Cat#
C1001/1001127; all from Altromin Spezialfutter, GmbH & Co.
KG). All these diets were prepared synthetically, containing
either casein (animal) or wheat gluten (plant) as a protein
source (Table 1). Mice were maintained on these diets for 3
weeks before the experiment started and then throughout the
whole experiment. In some experiments, the long-time effect
of the diet was analyzed by switching the diet already to the
parental generation of the mice. We measured gut permeability
for macromolecules in healthy mice fed with different diets. For
this purpose, we treated mice orally with 440 mg/kg of body
weight of FITC-labeled 3–5 kDmolecule of dextran (Merck, Cat#
FD4), andmeasured serum fluorescence 4 h later, as we published
previously (35).
Acute and Chronic Experimental Colitis
Acute and chronic experimental colitis was induced by 3%
dextran sulfate sodium (DSS, 36–50 kDa; MP Biomedicals, CA,
USA; Cat# 02160110) solution in sterile tap water ad libitum (36).
Acute colitis was evaluated on the last day of the experiment
(day 8) by using a disease activity index (DAI), colon length and
histological scoring system, as described previously (37). DAI
was determined as a mean of the following three parameters:
weight loss (none 0, 5% 1 point, 5–10% 2 points, 10–15% 3
points, >15% 4 points) stool consistency (solid 0 points, loose
stool that do not stick to the anus 2 points, and 4 points
for liquid stools that stick to the anus), rectal bleeding (none
0, positive test for occult blood 2 points, and 4 points for
gross bleeding). Occult blood in feces was evaluated with Fecal
Occult Blood Test (Okult-viditest Rapid; Vidia, Vestec, Czech
Republic), which is based on guaiacum reaction. Postmortem, the
mesenteric lymph nodes, spleen, and colon were collected from
TABLE 1 | Composition of the experimental diets.
aCD aHPD pCD pHPD
Protein [g/kg] 176.115 514.115 172.685 500.440
Fat [g/kg] 50.830 51.030 70.937 70.002
Fiber [g/kg] 40.450 39.370 30.358 30.490
Ash [g/kg] 54.943 63.343 53.100 51.522
Moisture [g/kg] 81.736 77.736 76.874 71.076
Mono and disaccharides [g/kg] 110.960 110.960 110.650 56.806
Polysaccharides [g/kg] 471.700 115.700 422.425 116.147
Energy [kcal/kg] 3518.055 3458.055 3641.566 3669.700
each mouse for further analyses. Colon shortening is an indirect
marker of colitis severity, so the entire colon was removed (from
caecum to anus) and measured by placing it without tension
on a ruler. Next, colon descendens was collected for histological
analysis, as described previously. Briefly, tissues were fixed in 4%
formalin, dehydrated in ethanol and embedded in paraffin. Four
micrometer sections were rehydrated and stained by hematoxylin
and eosin. Subsequent microscopic evaluation was made by
experienced pathologist in blinded manner.
Chronic DSS colitis was induced by three cycles consisting
of 5 days DSS and 9 days tap water. The analyses of colitis
severity by DAI, colon shortening, and mucosal damage were
performed as described above. The level of acute-phase protein
haptoglobin was determined in mouse serum using the mouse
haptoglobin ELISADuoset (Bio-Techne,Minneapolis,MN,USA;
Cat# DY4409).
Macrophages Depletion in vivo
Two days before DSS treatment, the mice were intraperitoneally
injected with 200µl of empty liposomes or liposomes loaded with
clodronate (Liposoma BV, Amsterdam, The Netherlands; Cat#
CP-010-010) to deplete blood monocytes and possibly some of
tissue macrophages in spleen and colon (38). To maintain and
promote the depletion through the whole DSS treatment period,
we injected the mice every 3 days starting 2 days before the DSS
introduction (day−2, day 1, and day 4).
Tissue Cell Cultures and Cytokines
Measurement
Colon tissue was cultivated ex vivo as described earlier (37).
Briefly, three millimeter punch biopsy from distal colons were
collected, weighted and cultured in 500 µl of complete RPMI
medium (Merck; Cat# R0883) containing 10% heat-inactivated
fetal bovine serum (Biochrom GmbH, Germany; Cat# S 0115)
and 1% Antibiotic-Antimycotic solution (Merck) in humidified
incubator (37◦C, 5% CO2) for 48 h. The supernatants were
collected and stored at −20◦C until analysis. Cytokines were
measured in tissue culture supernatants using appropriate ELISA
sets (Bio-Techne; Cat# DY410, DY406, DY401, and DY3626)
according to the manufacturer’s instructions.
Cell Preparation and Flow Cytometry
Analysis
Single cell suspensions from mesenteric lymph nodes (mLN)
and spleens were prepared by mechanical disruption and passed
through a 70µm cell strainer (Becton Dickinson; Cat# 352350).
After the washing (300 × g, 5min, 4◦C), red blood cells
from spleens were lysed by 5min incubation in RBC lysing
buffer (1mM EDTA, 150mM NH4Cl, 10mM KHCO3). The
supernatant with lysed red blood cells was removed and cells
were used for further analyses. Single cell suspensions from
colons were prepared using the published protocol (39). Next, the
cells were blocked by normal mouse serum and incubated with
fluorochrome-conjugated antibodies recognizing extracellular
epitopes (Supplementary Table 1). Then, the cells were treated
with eBioscienceTM Foxp3/Transcription Factor Staining Buffer
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Set (Thermo Fisher Scientific; Cat# 00-5523-00) and stained for
intracellular antigens (Supplementary Table 1). To distinguish
viable and dead cells, Fixable Viability Dye—eFluor 780 (Thermo
Fisher Scientific; Cat# 65-0865-18) was added to the staining
mix before fixation. Data were obtained by measuring the
samples on LSRII (BD Biosciences, CA) and the FlowJo software
(Tree Star Inc., Ashland, OR; RRID: SCR_008520) was used
for data analyses. Example of used gating strategy is shown
on Supplementary Figure 7.
Real-Time PCR
Three millimeter punch biopsy from distal colons were
collected, weighted, immediately immersed in RNAlater RNA
Stabilization Reagent (Qiagen, Hilden, Germany; Cat# 76106)
and stored at −20◦C until RNA extraction. Next, the tissue
was homogenized with ceramic beads (Lysing matrix D; MP
Biomedicals, Santa Ana, CA, USA; Cat# 116913050) using
FastPrep-24 (MP Biomedicals) and total RNA was isolated using
TRI reagent (Zymo Reseaerch, Irvine, CA, USA; Cat# R2050).
Next, the samples were treated with DNAse (TURBO DNA-
freeTM Kit; ThermoFisher Scientific; Cat# AM1907) according
the manufacturer’s instructions, and then reverse transcribed
into cDNA with the SuperScript IV Reverse Transcriptase
and the RNaseOUTTM Recombinant Ribonuclease Inhibitor
(ThermoFisher Scientific; Cat# 10777019), in the presence of
random primers (Generi Biotech s.r.o., Hradec Králové, Czech
Republic). The resulting cDNA was used for quantitative PCR
(CFX96 TouchTM, Bio-Rad) with gb SG PCR Master Mix
(Generi Biotech s.r.o.; Cat# 3005). Before use, each set of
primers (Supplementary Table 2) and RT-PCR conditions were
extensively optimized to ensure high efficiency of the reaction
and to avoid primer dimers. The cycling parameters were as
follows: 3min at 95 ◦C, 40 cycles of 30 s at 94 ◦C, 40 s at 59
◦C, and 50 s at 72 ◦C. Quantitative RT-PCR data were invariably
normalized to the expression levels of the reference gene
ribosomal protein S12 (Rps12) by means of the 2−11Ct method.
Gut Microbiota Analysis
Stool samples were collected at three different time points:
before switching to experimental diets (day −21), before disease
induction (day 0) and at the termination of the experiment
(day 8). Total DNA was extracted using MasterPure Complete
DNA and RNA Purification Kit (Epicenter, Illumina Inc.,
Madison, WI, USA; Cat# MC85200) with repeated bead-
beating in Lysing Matrix Y tubes using FastPrep homogenizer
(both MP Biomedicals) and PCR inhibitors were removed
using InhibitEx Tablets (Qiagen; Cat# 19590). DNA was
then standardized using Qubit dsDNA High Sensitivity
kit (Thermo Fisher Scientific). PCR targeting V3 and V4
regions of bacterial 16S was conducted using Kapa HiFi
DNA polymerase (Kapa Biosystems, Wilmington, MA, USA),
primers 341F (5′-CCTACGGGNGGCWGCAG- 3′) and
806R (5′-GGACTACHVGGGTWTCTAAT- 3′) (40) (Generi
Biotech s.r.o.) and 10% BSA (Merck; Cat# 8894). Cycling
conditions consisted of initial denaturation (94◦C, 3min)
followed by 30 cycles of denaturation (94◦C, 30 s), annealing
(54.2◦C, 45 s), extension (72◦C, 75 s) and final extension
(72◦C, 10min). For PCR targeting fungal ITS1 region, PPP
Master Mix (Top-Bio, Vestec, Czech Republic; Cat# P126)
with 18SF (5′-GTAAAAGTCGTAACAAGGTTTC-3′) and
5.8SR (5′-GTTCAAAGAYTCGATGATTCAC-3′) primers
and 10% BSA was used (41). Cycling conditions were 95◦C,
5min; 35 cycles of 95◦C, 30 s; 50◦C, 30 s; 72◦C, 60 s, and
72◦C, 10min. PCR triplicates were pooled and purified by
SequalPrep Normalization Plate Kit (Thermo Fisher Scientific;
Cat# A1051001). Samples within library were pooled and
sequencing adaptors were ligated using TruSeq DNA PCR-free
LT Sample Preparation Kit (Illumina, Madison, WI, USA; Cat#
FC-121-3001). Ligated libraries were quantified with KAPA
Library Quantification Kit (Kapa Biosystems,Wilmington,
MA, USA; Cat# KK4824) and sequenced on MiSeq Illumina
Platform using Miseq Reagent Kit v3 (Illumina; Cat# MS-
102-3003) at The Genomics Core Facility, CEITEC (Brno,
Czech Republic). Sequencing data were processed using QIIME
version 1.9.1 (42). Quality filtering, chimera detection and read
demultiplexing and read clustering were done as described
previously (43). Fungal reads were in addition extracted for ITS1
region using ITSx package (44). Identification of representative
sequences was done using RPD classifier (45) against bacterial
GREENGENES database 13.8 (46) and fungal UNITE database
7.2 (UNITE Community (2017): UNITE QIIME release. Version
01.12.2017. UNITE Community. https://doi.org/10.15156/
BIO/587481). Finally OTU table was produced. The data are
available in the Sequence Read Archive (SRA) http://www.ncbi.
nlm.nih.gov/sra under the submission number SUB4976849.
Briefly, for microbiota analysis, Chao1 index was used to
describe alpha diversity and Principle Coordinate Analysis
(PCoA) based on Bray Curtis dissimilarity metrics was used
to describe beta diversity. Next, Linear discriminant analysis
effect size (LEfSe; RRID: SCR_014609) was used to determine
the typical taxonomic profiles of communities in each group
(42, 47). Functional composition of a bacterial metagenome
was predicted by PICRUSt tool, using the 16S amplicon
data (48).
Gut Microbiota Metabolomics
At day 0, one fecal pellet of ∼25mg from each mouse was
collected and homogenized by vigorous vortexing in 500 µl of
phosphate buffered saline (PBS; pH = 7.4). Next, the sample
was centrifuged (13,000 × g for 10min) to remove particulate
matter and supernatant was transferred to a fresh microfuge
tube and centrifuged again. The resulting supernatant was
lyophilised at −58◦C overnight, re-suspended in D2O (500 µl)
containing 0.01% trimethylsilyl propionic acid as an internal
standard and transferred to a 5-mmNMR tube. TheNMR spectra
were recorded on a 600 MHz Bruker Avance III spectrometer
(Bruker BioSpin, Rheinstetten, Germany) equipped with a 5-
mm TCI cryogenic probe head. More detailed description of
experimental conditions of NMR analysis and corresponding
processing steps is given in Supplementary information. Total
protein content in fecal pellet filtrates was measured by
the bicinchoninic acid (BCA) assay (PierceTM BCA Protein
Assay Kit; ThermoFisher Scientific; Cat# 23227) according to
manufacturer’s recommendations.
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Statistical Analysis
One-way analysis of variance (ANOVA) with Tukey’s multiple
comparison test was used to compare multiple experimental
groups. Two-way ANOVA with Bonferoni post-test was used in
determination of significant weight andDAI changes. Differences
between two groups were evaluated using an unpaired two-tailed
Student’s t-test. The data are presented as the mean ± standard
deviation and differences were considered statistically significant
at P ≤ 0.05. GraphPad Prism statistical software (version 5.0,
GraphPad Software, RRID: SCR_002798) was used for analyses.
RESULTS
Protein-Rich Diet of Animal Origin Worsen
Acute Colitis While Protein-Rich Diet of
Plant Origin Does Not
To analyze the effect of quantity and source of dietary protein
on acute intestinal inflammation, we exposed mice fed with
animal or plant protein-based diets to DSS. We found that the
resulting colitis was significantly more severe in animals fed
with diet rich in animal protein (aHPD) than in animals fed
with diet containing normal amount of animal protein (aCD)
(Figure 1A). On the other hand, mice fed with diet rich in
plant protein (pHPD) were only marginally more susceptible
to acute colitis than animals fed with diet containing normal
amount of plant protein (pCD) (Figure 1B). Neither animal
protein- (Figure 1C) nor plant protein-based diets (Figure 1D)
influenced the proportions of regulatory T cells or Th17
cells in mesenteric lymph nodes. But unlike the increase in
plant protein, increase in animal protein led to significant
increase in colonic Ly-6Chi monocytes and their activation. The
intestinal inflammation in aHPD mice was accompanied with
increased colonic expression of anti-inflammatory TGF-β, pro-
inflammatory cytokines (TNF-α and IL-1β) and inducible NO
synthase. In the similar situation, pHPD generally decreased
their expression. Neither aHPD nor pHPD influenced the colonic
expression of IL-18 (Supplementary Figure 1). Furthermore, we
found that neither aHPD nor pHPD significantly changed animal
growth, gut permeability for macromolecules or gut cytokine
production in healthy mice (just before the DSS exposure)
(Supplementary Figure 2).
Since short term dietary change may have different
consequences than the whole life dietary change, we changed
diet to mice before mating and induced acute DSS colitis in
their offsprings. This way, we ensured that the mice were kept
on the aCD or aHPD their entire life. Nevertheless, even in this
setup, high amounts of animal protein significantly increased
sensitivity to acute DSS colitis (Supplementary Figure 3).
The aHPD Worsens the Intestinal
Inflammation in Chronic Colitis
Next, we induced chronic colitis in aCD and aHPD mice by
repeated administration of DSS. We found that aHPD worsened
the course of chronic DSS colitis. As shown on the weight
curve, every cycle of DSS treatment led to a more pronounced
inflammation in the aHPD-fed group (Figure 2).
Gut Microbiota Is Significantly Altered in
Both aHPD and pHPD-Fed Mice
Changing the diet from standard chow to synthetic diets, either
plant or animal protein-based, did not significantly changed
bacterial alpha diversity, but DSS-induced colitis led to significant
decrease in bacterial alpha diversity regardless of the diet
(Figure 3A). Interestingly, aHPD decreased bacterial diversity
significantly more than aCD (p < 0.05), but there was no
similar effect in plant-based diets. The PCoA plot showed clear
clustering among different diets and treatments among bacteria
(Figure 3B). First, there was a clear shift between day −21
and 0, induced by the diet change, which was more significant
in both animal protein-based diets than in the plant protein-
based ones. As expected, the protein source seemed to be more
important for the bacterial community composition than the
protein amount. This clustering became less clear at day 8, when
DSS-induced colitis seemed to have the major impact on bacteria.
There were particular bacterial taxa responsible for these shifts
(Figure 3C). Animal protein-based diets led to increased relative
abundance of genera Enterococcus, Streptococcus, Turicibater
(only aCD) and Escherichia, and families Peptostreptococcaceae
and Ruminococcaceaea. On the contrary, plant protein-based
diets enriched OTUs belonging to families Bifidobacteriaceae and
Desulfovibrionaceae in pCD and Coriobacteriaceae in pHPD and
both showed increased abundance of lactobacilli and families
Lachnospiraceae and Erysipelotrichaceae. DSS treatment resulted
in significant shifts in genera Bacteroides and Parabacteroides no
matter which protein source was used. In addition, we found
significant increase of Escherichia coli also in all groups; most
notably in both HPDs. It was enriched from 2.02, 1.01, 0.04,
and 0.27 to 10.03, 38.03, 17.34, and 34.03% in aCD, aHPD, pCD,
and pHPD, respectively. Compared to other groups, we found
some specific changes caused by colitis, such as more OTUs
assigned to genus Odoribacter and Akkermansia muciniphila in
mice consuming aHPD, and genus Staphylococcus in both HPDs.
Inmice consuming plant protein-based diets, colitis increased the
relative abundance of genus Enterococcus from 0.03 and 0.02% to
1.06 and 9.57% in pCD and pHPD, respectively.
Similarly as in bacteria, there was some decreasing tendency
in fungal alpha diversity in both CDs with the most striking
decrease in fungal diversity during colitis induction (day 0 vs.
8) (Figure 3D). The beta-diversity shifts induced by diet and
the effect of DSS-induced colitis were even more prominent for
fungi (Figure 3E) than for bacteria. These changes were driven
by marked shift in Ascomycota/Basidiomycota ratio before and
after DSS treatment (from 62.49, 51.56, 55.28, and 327.03
to 3513.00, 5087.29, 3693.16, and 27738.64 for aCD, aHPD,
pCD, and pHPD, respectively). Mice consuming animal protein-
based diets showed increased relative abundance of families
Cystofilobasidiaceae, Sporidiobolaceae, andMicrobotryomycetes
fam. incertae sedis. On the other hand, plant protein-based
diets led to increased abundance of order Pleosporales and
genera Piskurozyma, Cryptococcus, Ascochyta, and Aspergillus
(Figure 3F). After DSS treatment, Candida tropicalis seemed to
outgrow all other fungal species in all groups (from 0, 0, 0.3,
and 1.6% to 94.9, 94.3, 93.7, and 88.5% in aCD, aHPD, pCD, and
pHPD, respectively).
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FIGURE 1 | In immune-competent BALB/c mice, HPD of animal origin significantly worsens the severity of acute DSS-colitis (A) while HPD of plant origin does not
(B). Colitis severity was measured by disease activity index (weight loss, stool consistency, and rectal bleeding), colon shortening and damage to colon mucosa.
Neither aHPD (C) nor pHPD (D) changed the proportions of regulatory T cells (CD3+CD4+FoxP3+) or Th17 cells (CD3+CD4+RorγT+) in mesenteric lymph nodes,
while monocytes (CD11clowLy-6Chi) were significantly increased and more activated (iNOS+) in colons of aHPD fed mice. The weight loss was analyzed by two-way
ANOVA and other parameters by unpaired Student’s t-test; *p < 0.05 **p < 0.01 ***p < 0.001. Data are from one representative experiment out of 6 (A,C) or 3 (B,D)
independent experiments (n = 5–8).
FIGURE 2 | HPD of animal origin worsens the severity of chronic DSS-colitis. The weight loss was analyzed by two-way ANOVA and other parameters by unpaired
Student’s t-test; *p < 0.05 **p < 0.01 ***p < 0.001. Data are from one representative experiment out of 2 independent experiments (n = 5–8).
These taxonomic changes were reflected by the marked
shifts in microbial function, as predicted by PICRUSt algorithm
(Figure 3G). Almost all detected metabolic pathways or
functional proteins seemed to be enriched in microbiota at day
−21 when the mice were fed standard diet when compared to
synthetic diets. The dietary change led to a tendency to reduce
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FIGURE 3 | Gut microbiota, both bacterial and fungal, is profoundly changed by diet and intestinal inflammation. Comparison of impact of diet and gut inflammation
on bacterial (A) and fungal (D) alpha diversity using Chao1 diversity index. Principal coordinates analysis (PCoA) plot using the Bray-Curtis distance metric shows the
compositional differences induced by diet and inflammation at the diet switch (day −21) and before (day 0) and after the DSS treatment (day 8) for bacteria (B) and
fungi (E). Each colored orb represents the microbiota composition in feces of one mouse. Each color represents one group of mice at the day −21, 0, or 8. Linear
discriminant analysis effect size (LEfSe) for bacteria (C) and fungi (F) shows taxonomic units typical for each group. The first taxonomic unit represents phylum (p) and
the second represents the lowest taxonomic rank revealed by the analysis, it being class (c)—order (o)—family (f)—genus (g)—species (s) or variety (v). Heatmap of
bacterial gene functional predictions using the PICRUSt algorithm showing the changes in KEGG level-3 pathways (columns) and experimental groups (row) (G). Fecal
protein content, as measured by BCA assay and amounts of SCFA, phenylalanine and BCAA, as measured by NMR-based metabolomics (H). The changes in alpha
diversity were analyzed by ANOVA with Tukey’s multiple comparison test;
†
p < 0.05 for changes in aCD or pCD and *p < 0.05 **p < 0.01 for the other comparisons.
The metabolomic data were analyzed by Wilcoxon-Mann-Whitney test; *p < 0.05 **p < 0.01 ***p < 0.001 (n = 3). Boxplot legend: asterisk—mean value, black
dots—metabolites’ intensities in particular samples.
some pathways especially in plant protein-based diets at day 0
and partly also in aCD at day 8. Among proteins with the highest
reduction belonged “bacterial motility proteins,” “secretion
system” and “two-component system.” Interestingly, these
pathways were slightly enriched after DSS treatment on day 8 in
aHPD and pHPD. Moreover, overall pathways enrichment was
visible at both HPDs on day 8 partly getting a pattern similar as
at day−21.
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Metabolomics Reveals Shifts Between
Animal and Plant Protein Diets
We compared the fecal metabolite profile among healthy
mice (day 0) on different diets to better understand the
luminal environment that could affect the sensitivity to
intestinal inflammation. We found that gluten was more
resistant to digestion than casein, which led to an increase
in stool protein content, especially in pHPD (Figure 3H).
Next, we identified several distinct metabolites that may
influence experimental colitis induction, using NMR-based
approach. We found that while there were no major differences
between matched normoproteic and hyperproteic diets, the
animal and plant protein-based diets each led to production
of different metabolites suggesting that the source, and
not the amount, of protein was important. Total short-
chain fatty acids (SCFA; acetate, propionate, butyrate) were
increased in fecal content of mice fed with both gluten-
based diets as compared to the casein-based ones. Nevertheless,
there were no significant differences in SCFA related to
protein amount. Similarly as SCFA, phenylalanine or total
branched-chain amino acids (BCAA; valine, leucine, isoleucine)
were also higher in plant protein-based diets and similar
trends were also visible in glutamate, glutamine, citrate,
threonine, and arabinose. Only cytidine showed any tendency
for an increase in fecal content of animal protein fed mice
(Supplementary Figure 4).
Both Microbiota and aHPD Are Needed for
the Pro-inflammatory Effect of aHPD
First, we induced acute intestinal inflammation in germ-
free (GF) mice on different diets, to find that both aCD
and aHPD had similar severity of colitis (Figure 4A). Then
we transferred gut microbiota from either healthy aCD-
fed or healthy aHPD-fed mice to GF mice fed standard
diet. Surprisingly, we found that microbiota transferred
from aHPD-fed mice protected the mice from acute
colitis (Figure 4B).
The Pro-inflammatory Effect of aHPD Is
Not Dependent on Adaptive Immunity
The lack of any differences between aCD or aHPD mice
in regulatory T cells and Th17 cells (Figure 1C) suggested
that adaptive immunity was not responsible for the pro-
colitic effect of aHPD. To gauge the importance of adaptive
immunity in the pro-inflammatory effect of aHPD, we repeated
experiments with acute DSS colitis in mice lacking both T and
B lymphocytes (RAG2−/−). Similarly as in immuno-competent
BALB/c mice, aHPD-fed RAG2−/− mice were significantly more
sensitive to the acute intestinal inflammation than aCD-fed mice
(Figure 5A). Moreover, colons of aHPD mice produced more
pro-inflammatory cytokines TNF-α, IL-6, and IL-33 as compared
to aCD mice (Figure 5B). Although there was slightly higher
weight loss in pHPD mice, they were not more sensitive to acute
colitis than pCD mice (Supplementary Figure 5).
FIGURE 4 | HPD of animal origin does not worsen the severity of acute
DSS-colitis in germ-free animals (A), but microbiota transferred from aHPD fed
mice mitigates colitis severity (B). The weight change shows percentage of
weight gain/reduction between day 0 and 8 of DSS treatment. All parameters
were analyzed by unpaired Student’s t-test; ***p < 0.001 (n = 5–8).
Inflammation in aHPD Fed Mice Is Driven
by Monocytes and Subsequent
Pro-inflammatory Tuning of Innate
Immunity
To analyze the importance of monocytes, we injected clodronate-
containing liposomes (LIPO+) or empty liposomes (LIPO-)
intraperitoneally every 3 days starting 2 days before the start
of DSS. We found that this treatment abrogated the pro-colitic
effects of aHPD in both BALB/c (Supplementary Figure 6)
and RAG2−/− (Figure 6A) mice. In RAG2−/− mice, aHPD
increased proportions of macrophages in spleen and neutrophils
in colon (Figures 6B,C). LIPO+ treatment significantly reduced
number of splenic Ly-6Clow macrophages and colonic Ly-6Chi
monocytes and neutrophils in aHPD-fed mice (p < 0.001
in all cases). Interestingly, while clodronate liposomes were
capable to markedly reduce the proportions of macrophages
in the spleen, they did not have such effect on colonic
macrophages (Figure 6C).
DISCUSSION
Host’s homeostasis is adjusted by continuous interactions
between microbiota and immune system. Thus, change in
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FIGURE 5 | In immune-deficient RAG2−/− mice, aHPD worsens the severity
of acute DSS-colitis (A), which is accompanied with the increase in TNF-α,
IL-6, IL-1β, and IL-33 in the colon (B). The weight loss was analyzed by
two-way ANOVA and other parameters by unpaired Student’s t-test; *p < 0.05
**p < 0.01 ***p < 0.001. Data are from one representative experiment out of 3
independent experiments (n = 6–7).
microbiota caused by diet could lead to a shift in immune system
reactivity and ultimately to changes in sensitivity to inflammatory
diseases (49).
Here, we used animal model of ulcerative colitis to analyze
how diet-microbiota-host interactions influence the sensitivity
to intestinal inflammation. We found that HPD with protein
of animal origin worsens acute colitis while HPD with
protein of plant origin does not. Moreover, changing the
diet 3 weeks before has similar outcome for the colitis as
switching the diet already to the previous generation before
conception. This suggests that increased sensitivity of mice
fed aHPD is not a result of the slower adaptation of the
organism to the fundamentally changed macronutrient ratio
(13). While changes in dietary protein source in humans
lead to profound changes in gut microbiota metabolism and
host’s gut mucosa transcription, casein-rich diet did not induce
inflammation but influenced central homeostatic principles such
as cell to cell signaling, cell cycle or death (50). This is in
agreement with studies performed in IBD patients, where animal
(especially milk) protein consumption correlated positively
and consumption of plant protein negatively with incidence
of Crohn’s disease (20). In these cases, however, proteins
in diets are often naturally accompanied with micronutrients
with the ability to mitigate (51–53) or exacerbate (54–56)
intestinal inflammation in animal models. To minimize the
effect of these secondary bioactive molecules, we used well-
matched and fully synthetic diets containing only one source
of protein—casein or wheat gluten, respectively—in either
normal (aCD/pCD) or high (aHPD/pHPD) amounts. The
type and composition of other components was the same in
all diets used. Diets of animal origin contain slightly more
fiber (1% of total mass) and slightly less fat (2% of total
mass). This, however, probably did not significantly influence
the induction of colitis, because both fat and fiber content
were similar between normo- and hyper-proteic diets of
either type.
Our data support the recent study showing that high amounts
of dietary protein accelerate carcinogenesis in AOM/DSS model
of colon cancer by increase the colonic inflammation (57).
Indeed, we confirmed that colons from colitic aHPD-fed mice
produce more iNOS than colons of aCD-fed mice, but this
difference seems to be more related specifically to casein than any
protein. We found increased colonic expression of TGF-β, which
forms one of the main regulatory feedback loop involving colonic
macrophages and Tregs (33). Its increase during the more severe
colitis in aHPD-fed mice may represent a local damage control
and its suppressive effect on pro-inflammatory cells was probably
counteracted by increased levels of pro-inflammatory cytokines,
thus insufficient to regulate the inflammation in aHPD mice.
Main mechanism of acute DSS colitis is a damage to gut
barrier function (58), but if it was compromised even before DSS
exposure, it may accelerate colitis. We found that neither of the
two high-protein diets significantly increased gut permeability
for macromolecules in healthy mice, suggesting that the barrier
was not compromised before the exposure to DSS. This is not in
agreement with the study of Llewellyn et al. (27), who found that
dietary casein increases gut permeability in healthy mice. We can
speculate that this discrepancy was due to the better adaptation
of our animals to the abrupt dietary change caused by the longer
exposure (3 weeks instead of 1 week), different initial microbial
colonization or differences in mouse strain (BALB/c instead of
C57BL/6) used.
Diet is a major modulator of the gut intestinal microbiota
thus can significantly influence the immune reactivity (14).
There is a steep decrease in bacterial and fungal diversity as
a result of DSS-induced colitis, which is typical feature shared
with human UC (43). In the mice fed animal protein-based
diets, we identified several bacterial genera, such as Enterococcus,
Streptococcus and Peptostreptococcus, which have been formerly
shown in association with IBD (59). Moreover, in colitic aHPD-
fed mice, we found increased relative abundance of genera
Odoribacter and Akkermansia which has been also linked to
gastrointestinal diseases. Bacterial and fungal genera such as
Streptococcus, Peptostreptococcus, Escherichia and Candida are
known to express several virulence factors including proteolytic
activity and biofilm formation that could improve their viability
and adhesion in the gut and thus influence disease induction
(60). While Candida mostly appeared after DSS course in all
tested groups, streptococci, and peptostreptococci were present
in the animal protein groups even before colitis induction and
were massively outgrown with E. coli after DSS treatment. In our
model, both Candida and E. coli were increased after feeding
animal protein diet and thus they may facilitate detrimental
effects of DSS treatment especially in aHPD group. These two
microbes are often associated with diseased IBD patients (61, 62),
and even their co-occurrence is necessary for severe forms of
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FIGURE 6 | Intraperitoneal administration of clodronate liposomes is sufficient to mitigate the colitis in RAG2−/− (A) mice. Splenic (B) and colonic (C) populations of
neutrophils, macrophages and monocytes as analyzed by flow cytometry in colitic RAG2−/− mice treated either with empty (–LIPO) or clodronate-loaded (+LIPO)
liposomes. The weight loss was analyzed by two-way ANOVA and other parameters by unpaired Student’s t-test; *p < 0.05 **p < 0.01 ***p < 0.001. Data are from
one representative experiment out of 3 independent experiments (n = 6–7).
experimental colitis (63). Unfortunately, mechanisms of their
cooperation are not yet known.
Prediction of proteins or metabolic pathways by PICRUSt
analysis revealed some microbiota features that can be linked
to increased susceptibility to gut inflammation. It has been
shown that several strains of E. coli use flagella to improve their
mobility in the gastrointestinal tract under acidic pH and in
environment with higher levels of bile salts (64). Moreover,
various transmembrane secretion systems are associated
with pathobionts and pathogens in the gastrointestinal tract.
Transport and secretion of metabolites including toxins can
compromise the gut mucosa and even initiate inflammation
(65). Two-component systems basically modulate microbial
transcription in the way of quick adaptation to changing
conditions thus having important role in bacterial survival. In
our model, especially in HPDs, bacteria residing inflamed gut
were equipped with these mechanisms improving their viability
and promoting their possible pathogenicity.
By metabolomics analysis, we intended to define the
conditions right before colitis induction and possibly connect
them to the subsequent colitis course. Known for mostly
beneficial effects, we determined the levels of SCFA. Though
they are typically produced from saccharides, recent research
has shown that also protein can serve as a substrate for their
production (66). Nevertheless, when we compared animal and
plant proteins intestinal digestion we found that animal protein
derived the smallest levels of SCFA while plant protein showed
quite high production. This could be associated with differences
in endogenous digestibility of animal and plant proteins. In line
with others (21, 22), our results are showing the later one is
less digestible and thus available for further processing in the
colon. Moreover, we found that plant protein diet led to milder
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colitis though some effect of DSS treatment was still visible. Since
butyrate, as a main component of SCFA, has been shown to
reduce experimental colitis in several studies we may speculate
that its increased presence attenuated colitis also in our case
(67). Potentially beneficial effects on colitis course could also
have other metabolites that we found enriched after feeding plant
protein diets. For instance, elevated phenylalanine could increase
anti-inflammatory response via activation of epithelial calcium
receptor (68), and similarly, increased glutamine could reduce
NO and pro-inflammatory cytokines production (69). On the
other hand, threonine supplementation has been shown to delay
epithelial regeneration after colitis (70). Taken together, plant
protein metabolites seem to have a potential to reduce colitis
probably by a combined effect including strengthening of gut
barrier and decreasing pro-inflammatory stimulation.
To further analyze the importance of gut microbiota in aHPD
colitogenic effect, we used GF mice. Nevertheless, we did not
find any significant differences in colitis severity between aCD-
and aHPD-fed GF mice suggesting that the pro-inflammatory
effect of aHPD is dependent on the presence of microbiota.While
the absence of microbiota decreases the sensitivity of animals to
acute DSS-induced colitis (71), it does not completely prevent
it. This fact could even increase the sensitivity of our model to
gauge the pro-colitic effect of aHPD. Next, we transferred gut
microbiota from aCD or aHPD fed mice to GF mice that were
not exposed to either diet and induced acute colitis in these
mice. We found that mice transferred with microbiota from
aHPD do not have significantly more severe colitis than these
transferred with microbiota from aCD. This suggests that the
both specific microbes and specific substrate (casein) needs to
be present at the same time to increase sensitivity to intestinal
inflammation. This is in agreement with the conclusions of the
recent study of Llewellyn et al. (27). Interestingly, microbiota
transferred from aHPD-fed mice made mice significantly less
sensitive to colitis than microbiota from aCD. Unfortunately,
we are not able to explain this counter-intuitive effect of aHPD-
associated microbiota.
While they are not strictly needed for the acute DSS colitis
to develop, (72), the absence or increased presence of T cells
may influence its severity (71, 73). Therefore, we compared the
proportion of regulatory T cells or Th17 cells in mesenteric
lymph nodes of animals fed HPDs with their appropriate
controls. Neither aHPD nor pHPD changed either of these T
cell subsets, suggesting that T cells are not essential for the
pro-inflammatory effect of aHPD. To test this hypothesis, we
induced acute DSS colitis in immune-deficient RAG2−/− mice
on different diets. Similarly as immune-competent BALB/c mice,
aHPD-fed RAG2−/− mice are more sensitive to acute colitis.
We found that severe colitis in aHPD-fed RAG2−/− mice is
associated with high levels of homeostatic cytokine IL-33 and
pro-inflammatory cytokines TNF-α and IL-6. While the former
is produced by damaged epithelium signaling for repair (74),
possibly secondary to a higher degree of epithelial damage in
aHPD-fed mice, the latter are produced in high quantities by
pro-inflammatory monocytes recruited from the blood (34).
We found that colonic monocytes were significantly
increased in aHPD fed mice after colitis induction. To further
study the effect of this mononuclear phagocytic system on
aHPD-induced colitis sensitivity, we depleted macrophages
in systemic compartment with clodronate (38). We found
that this intervention abrogated the pro-colitic effect of
aHPD and significantly decreased the numbers of colonic
Ly-6Chi monocytes. Our results suggest that mainly monocytes
recruited through blood stream are the drivers of aHPD-
associated severe colitis whereas local macrophages have
rather the anti-inflammatory regulating role. This is in line
with findings that depletion of resident macrophages leads
to more severe colitis (75). Interestingly, colonic neutrophils
are decreased as well, and since they are not sensitive to a
clodronate liposome-mediated depletion (38), this is probably
caused by decrease in their recruitment due to milder colitis.
Moreover, splenic monocytes in aCD fed mice were more
effectively depleted by clodronate liposomes than these in
aHPD fed mice probably because induction of phagocytosis
in aCD fed mice, which makes them more susceptible to
clodronate-induced cell depletion. In conclusion, we have shown
that interactions between dietary protein of animal origin
(casein) and gut microbiota increases sensitivity to intestinal
inflammation. This pro-inflammatory effect is not dependent
on adaptive immunity, but it is driven by activated Ly-6Chi
monocytes and subsequent pro-inflammatory tuning of innate
immunity. Our results suggest that IBD patients may benefit
from changing the source of dietary protein and outline the
possibility to use specific antibiotic or probiotic treatment aimed
at gut microbiota.
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